Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-30.7M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$6.46M
-
Number of sells
-
-31
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q2 2025
34 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q2 2025.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
.
Largest 10 shareholders include 1 NORTH WEALTH SERVICES LLC (0 shares), Vanguard Personalized Indexing Management, LLC (0 shares), Intellectus Partners, LLC (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), SBI Securities Co., Ltd. (0 shares), VANGUARD GROUP INC (0 shares), JPMORGAN CHASE & CO (0 shares), Jefferies Financial Group Inc. (0 shares), Virtu Financial LLC (0 shares), and FIRETHORN WEALTH PARTNERS, LLC (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.